Cost-effectiveness analysis of cadonilimab plus bevacizumab and chemotherapy for persistent, recurrent, or metastatic cervical cancer

ObjectiveThe aim of this study is to investigate the cost-effectiveness of cadonilimab plus bevacizumab and chemotherapy in the first-line treatment for patients with persistent, recurrent, or metastatic cervical cancer from a healthcare system perspective in China.MethodsA partitioned survival mode...

Cur síos iomlán

Na minha lista:
Sonraí Bibleagrafaíochta
Main Authors: Kaixuan Wang, Shixian Liu, Ruixue Wang, Lei Dou, Jie Gao
Formáid: Artigo
Teanga:Inglês
Foilsithe: Frontiers Media S.A. 2025-06-01
Sraith:Frontiers in Immunology
Ábhair:
cost-effectiveness
cadonilimab
cervical cancer
bevacizumab
chemotherapy
Rochtain Ar Líne:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1594786/full
Clibeanna: Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!

Míreanna Comhchosúla